Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine
Clinical trial NCT04477096 · COMPLETED
Trial details
- NCT number
- NCT04477096
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2020-09-24
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.